Search

Displaying results 9931 - 9940 of 10000 in total
  1. Drug

    Stapokibart

    go.drugbank.com/drugs/DB18990
    Investigational

    Stapokibart is under investigation in clinical trial NCT06424470 (Study on the Treatment of Prurigo Nodularis With Stapokibart Injection).

  2. Drug

    norUrsodeoxycholic acid

    go.drugbank.com/drugs/DB16260
    Investigational

    norUrsodeoxycholic acid is under investigation in clinical trial NCT03872921 (Norursodeoxycholic Acid vs Placebo in PSC).

  3. Drug

    Poseltinib

    go.drugbank.com/drugs/DB16299
    Investigational

    Poseltinib is under investigation in clinical trial NCT02628028 (A Study of LY3337641 in Rheumatoid Arthritis).

  4. Drug

    Sodelglitazar

    go.drugbank.com/drugs/DB16332
    Investigational

    Sodelglitazar is under investigation in clinical trial NCT00196989 (Study in People With Type 2 Diabetes).

  5. Drug

    Ziresovir

    go.drugbank.com/drugs/DB15145
    Investigational

    Ziresovir is under investigation in clinical trial NCT03699202 (Anti-RSV Study in Chinese Patients (ASCENT)).

  6. Drug

    Thyrotropin

    go.drugbank.com/drugs/DB15263
    Investigational

    Thyrotropin is under investigation in clinical trial NCT01348191 (Detection of Thyrotrophin Receptor in Human Myometrium).

  7. Drug

    EMI-137

    go.drugbank.com/drugs/DB19174
    Investigational

    EMI-137 is under investigation in clinical trial NCT03360461 (EMI-137 in Laparoscopic Colonic Resections).

  8. Drug

    Troriluzole

    go.drugbank.com/drugs/DB15079
    Investigational

    Troriluzole is under investigation in clinical trial NCT03701399 (Troriluzole in Adult Subjects With Spinocerebellar Ataxia).

  9. Drug

    MK-0767

    go.drugbank.com/drugs/DB12055
    Investigational

    MK0767 has been used in trials studying the treatment of Dyslipidemia, Diabetes Mellitus, Type 2 Diabetes Mellitus, Diabetes Mellitus, Type 2, and Diabetes Mellitus, Type II, among others.

  10. Drug

    JANX013

    go.drugbank.com/drugs/DB33937
    Experimental

    JANX013 is a biologic drug. JANX013 is under investigation in clinical trial NCT07813637 (Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC).